Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04121325 · ClinicalTrials.gov registry record
Gastric Electrical Stimulation for Abdominal Pain in Gastroparesis
A clinical trial, sponsored by University of Louisville.
- Terminated
- Registry status
- 4
- Enrollment target
NCT04121325 is a clinical trial that was terminated before completion, run by University of Louisville. The registered enrollment target is 4 participants.
The verdict
NCT04121325 was terminated before completion, sponsored by University of Louisville.
- TERMINATED
- Registry status
- 4 participants
- Enrollment target
Study Summary
To conduct a pilot study to evaluate the effects of new GES programming settings on abdominal pain in patients with gastroparesis and existing GES devices, whose abdominal pain has so far been refractory to drugs and/or devices.
Interventions
- DEVICE Enterra
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2019-12-18 |
| Est. Completion | 2020-03-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04121325
The ClinicalTrials.gov registry entry for NCT04121325 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Enterra is the first listed.
NCT04121325 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04121325 about?
NCT04121325 is a clinical study titled "Gastric Electrical Stimulation for Abdominal Pain in Gastroparesis". To conduct a pilot study to evaluate the effects of new GES programming settings on abdominal pain in patients with gastroparesis and existing GES devices, whose abdominal pain has so far been refractory to drugs and/or devices.
What is the current status of trial NCT04121325?
This trial is currently terminated. The enrollment target is 4 participants. The study started on 2019-12-18. Estimated completion is 2020-03-13.
What interventions are being tested in trial NCT04121325?
The interventions under investigation include: Enterra (DEVICE).
Who is sponsoring clinical trial NCT04121325?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.